EN DE
Watch Jubilant Ingrevia Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Jubilant Ingrevia Limited (JUBLINGREA) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of Jubilant Ingrevia Limited stock ₹388, price ₹592, that is 34.5% below the price, quality 55 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials IN · ISIN INE0BY001018

JI Jubilant Ingrevia Limited logo Broad data Nov 15, 2026

Jubilant Ingrevia Limited

JUBLINGREA · NSE

Expensive (fair value 35% below the price) and price moving sideways, but solid company: meets 1 of 3 rules.

Get notified free when this changes
Low debt 
Generates free cash flow 
0.8% dividend yield · Well covered
Broad data 
Last quarter vs. a year ago: revenue +25%, profit +61%. 
Quality 55/100 
Price moving sideways (no uptrend) 
Thin margins · 7.1% net margin (TTM) 
Mixed vs. peers (7/14) 
Moderate moat 48/100 · thin data
Fair value ₹387.66 · Overvalued 
Weak Growth (revenue 3y −2.5 %/yr in INR) 
⟳ Cyclical
Watch Jubilant Ingrevia Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹847.43 ₹348.09 Fair Value ₹387.66 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.

How to read this chart

60‑month range ₹348.09 – ₹847.43 · fair‑value band ₹202.70 – ₹484.57 · the ₹591.50 price screens above the ₹387.66 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.

Follow Jubilant Ingrevia in your weekly email

Every Wednesday you see whether Jubilant Ingrevia is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates.

Show moreShow less

The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions.

The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol.

In addition, it provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers.

The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020.

Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.

Stock analysis

Jubilant Ingrevia Limited (JUBLINGREA) currently trades at ₹591.50, while our model-based Fair Value estimate is ₹387.66, 35% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ₹592.88 per share, and 2 of the 26 models we run sit above the ₹591.50 price.

Bear case: the Dividend Discount group reads lowest at ₹75.79, and 24 of the 26 models stay below the price. Data coverage for this calculation is high.

Scenario range: ₹202.70 (bear) to ₹484.57 (bull), the price of ₹591.50 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 55/100 (solid quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Jubilant Ingrevia Limited reported revenue of ₹43.9B in FY2026 versus ₹49.1B in FY2022, a compound −2.8%/yr. Reported net income was ₹2.8B in FY2026, compounding −12.6%/yr from FY2022.

Key figures

Market cap ₹93.9B (≈ $1,000M) Small · P/E ratio 29.2 · P/S ratio 1.91 · EPS (TTM) ₹20.29 · Dividend yield 0.8% · Net margin 7.1% · Return on equity 11.0% · Return on assets (EBIT) 10.1% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades about 22% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at −35%, JUBLINGREA screens cheaper than that median.

Fair Value models

Bear ₹202.70 Fair Value ₹387.66 Bull ₹484.57
Price ₹591.50 · Downside -34.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹9.68 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF ₹144.13 ₹206.18 ₹387.57 75
EPV ₹128.83 ₹145.50 ₹159.05 74
Growth DCF ₹134.45 ₹216.50 ₹362.91 74
All 26 models by family
DCF Models
FCF DCF ₹144.13 ₹206.18 ₹387.57 75
Owner Earnings ₹138.59 ₹281.75 ₹532.93 70
5Y Revenue Exit ₹202.70 ₹372.27 ₹728.36 66
5Y EBITDA Exit ₹290.80 ₹550.07 ₹1,059 69
5Y P/E Exit ₹234.37 ₹549.43 ₹981.09 65
10Y Revenue Exit ₹172.96 ₹413.22 ₹574.12 63
10Y EBITDA Exit ₹235.94 ₹575.96 ₹1,182 61
10Y P/E Exit ₹200.48 ₹471.71 ₹921.09 58
Earnings-Based
Graham-Dodd ₹119.82 ₹835.62 ₹1,173 61
Lynch FV ₹333.58 ₹476.55 ₹619.51 59
PEG = 1.0 ₹333.58 ₹476.55 ₹619.51 55
EPV ₹128.83 ₹145.50 ₹159.05 74
Dividend Discount
Gordon GGM ₹46.22 ₹77.91 ₹101.62 66
DDM Multi-Stage ₹46.22 ₹73.66 ₹83.78 65
Multiples
P/E Multiple ₹290.74 ₹387.66 ₹484.57 63
P/S Multiple ₹224.67 ₹299.55 ₹374.44 58
P/B Multiple ₹399.90 ₹533.21 ₹666.51 55
EV/EBIT ₹278.38 ₹383.89 ₹489.41 66
EV/EBITDA ₹339.35 ₹465.18 ₹591.02 67
EV/Revenue ₹187.76 ₹284.59 ₹381.41 53
Asset-Based
NCAV (Graham) ₹98.00 ₹131.32 ₹196.00 54
Growth DCF
Growth DCF ₹134.45 ₹216.50 ₹362.91 74
Rev-Margin DCF ₹205.32 ₹426.55 ₹845.36 66
Economic Profit
Residual Income ₹152.48 ₹159.58 ₹176.83 74
ROIC Compounder ₹128.83 ₹145.50 ₹159.05 70
Growth Earnings
Growth-Adj P/E ₹415.02 ₹592.88 ₹770.74 65

Open the full fair value analysis →

Quality Score breakdown

Overall quality 55/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 42
How much profit the company makes from its sales and capital
Quality Growth 35
Are margins and returns getting better?
Cashflow 38
Do the profits arrive as real cash?
Financial strength 67
Debt, balance sheet and risk of trouble
Investment 67
Does it invest with discipline instead of growing at any price?
Low Volatility 77
How calm the share price moves, does not count
Price momentum 22
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 20
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+6.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+45.2%
Start year 2021 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+36.5%
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+1.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+1.0%
Dividend (yield on the price)0.8%
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 9%

Growth Forecast

A lot of optimism in the price
The price assumes less growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+38.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+9.7%
Yearly sales growth analysts expect, extended to five years.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +33.1% a year for the price and +5.3% for the forecasts.
Forecast 2027 (sales)+24.5%
Forecast 2028 (sales)+7.3%
Projected 2029 (sales)+6.6%
Projected 2030 (sales)+6.0%
Projected 2031 (sales)+5.3%

JUBLINGREA screens overvalued: fair value 35% below the price. Compare with Linde plc →

Compare Jubilant Ingrevia Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 756 stocks

Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 55 · Above median
Fair Value upside −34.5% · Below median
Profitability
Return on equity (12 months) 11.0% · Above median
Return on assets 5.1% · Above median
Net margin (12 months) 7.1% · Above median
Operating margin (12 months) 12.2% · Above median
Growth and dividend
Revenue growth (quarter YoY) 25.2% · Above median
Dividend yield (12 months) 0.8% · Below median
Balance sheet
Debt / equity 0.10× · Below median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (12 months) 29.2× · Pricier than median
P/B 3.00× · Priciest 25%
P/S (12 months) 1.91× · Pricier than median
Price / free cash flow (fiscal year) 57.7× · Priciest 25%
EV/EBITDA 13.4× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 6
FUTURE (revenue growth)100 · sector 69
PAST (return on equity)44 · sector 26
HEALTH (low debt)95 · sector 95
DIVIDEND (yield)17 · sector 31

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wanhua Chemical Group 600309 ¥69.50 ¥68.03 −2% vs JUBLINGREA
Linde plc LIN $523.46 $446.62 −15% vs JUBLINGREA
PPG Industries, Inc PPG $121.97 $77.68 −36% vs JUBLINGREA
DSM-Firmenich AG DSFIR CHF 96.60 CHF 58.32 −40% vs JUBLINGREA
Asian Paints Limited ASIANPAINT ₹2,573 ₹1,479 −43% vs JUBLINGREA
The Sherwin-Williams Company SHW $350.54 $152.59 −56% vs JUBLINGREA
Givaudan SA GIVN CHF 4,091 CHF 1,618 −60% vs JUBLINGREA
EMS-CHEMIE HOLDING AG EMSN CHF 839.00 CHF 284.63 −66% vs JUBLINGREA
Ecolab Inc ECL $308.41 $97.18 −68% vs JUBLINGREA
Air Products and Chemicals, Inc APD $313.90 $75.33 −76% vs JUBLINGREA

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Jubilant Ingrevia Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Jubilant Ingrevia Limited Fair Value". https://www.fairvalue-calculator.com/stock/JUBLINGREA

Frequently asked questions

Is Jubilant Ingrevia Limited (JUBLINGREA) overvalued or undervalued?
As of Nov 15, 2026, our model estimates a fair value of ₹387.66 versus a price of ₹591.50, about 35% lower (overvalued).
What is the fair value of JUBLINGREA?
Our model-based fair value for Jubilant Ingrevia Limited is ₹387.66 (as of Nov 15, 2026), built from audited fundamentals. The current price: ₹591.50.
What is the quality score of JUBLINGREA?
Jubilant Ingrevia Limited has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Jubilant Ingrevia Limited (JUBLINGREA)?
Our model-based price target is the fair value of ₹387.66 (as of Nov 15, 2026) from 26 valuation models. Cautious scenario ₹202.70, optimistic scenario ₹484.57. It is a calculation from audited fundamentals, not an analyst target.
What is the Jubilant Ingrevia Limited stock forecast for 2026?
Our models put fair value at ₹387.66, about 35% lower versus a price of ₹591.50 (overvalued). Cautious scenario ₹202.70, optimistic scenario ₹484.57. The calculation is refreshed regularly with new filings.
What is the revenue of Jubilant Ingrevia Limited (JUBLINGREA)?
Jubilant Ingrevia Limited reported trailing-twelve-month revenue of about ₹49.2B (latest available figure, as of Nov 15, 2026).
Does Jubilant Ingrevia Limited pay a dividend?
Jubilant Ingrevia Limited currently shows a dividend yield of 0.85% relative to its recent price (as of Nov 15, 2026).
How much is the dividend of Jubilant Ingrevia Limited (JUBLINGREA) and when is the ex-dividend date?
Jubilant Ingrevia Limited pays a dividend of ₹5.00 per share a year, a dividend yield of 0.8%. The last ex-dividend date was Jul 24, 2026. A dividend has been paid every year since at least 2021. The payout ratio is 24.6% of earnings. Free cash flow covers the dividend 2.06 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Jubilant Ingrevia Limited (JUBLINGREA)?
For today's price to be fair in a discounted-cash-flow model, Jubilant Ingrevia Limited would have to grow free cash flow by 38.6 % per year for five years (discount rate 12.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 45.2 % per year. As of Nov 15, 2026.
What discount rate (WACC) does the fair value of JUBLINGREA use?
Our models discount Jubilant Ingrevia Limited at 12.4 %: a base by market capitalisation (small), damped by beta 0.28, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Jubilant Ingrevia Limited that is +38.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.4 %) and the same formula as our fair value.
How much growth has Jubilant Ingrevia Limited (JUBLINGREA) delivered so far?
Over the past 5 years revenue at Jubilant Ingrevia Limited grew 45.2 % a year. The price currently implies free-cash-flow growth of +38.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Jubilant Ingrevia Limited (JUBLINGREA) growing?
The median revenue growth in the sector is +7.3 % a year. That is the yardstick for the growth priced into Jubilant Ingrevia Limited (+38.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Jubilant Ingrevia Limited (JUBLINGREA)?
The free-cash-flow yield on the price is 1.73 %: that much free cash flow Jubilant Ingrevia Limited produces per unit of market value. When it exceeds the discount rate of our models (12.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Jubilant Ingrevia Limited (JUBLINGREA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Jubilant Ingrevia Limited it is ₹387.66 per share (as of Nov 15, 2026), against a price of ₹591.50. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Jubilant Ingrevia Limited stock overvalued or undervalued in 2026?
As of Nov 15, 2026, JUBLINGREA trades above its calculated fair value: price ₹591.50, fair value ₹387.66, a gap of about −35% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of JUBLINGREA?
No. The price is what the market pays today (₹591.50); the fair value is what the company's own numbers justify (₹387.66). For Jubilant Ingrevia Limited the two are ₹203.84 per share apart. That gap is exactly why we show both numbers side by side.
How much is Jubilant Ingrevia Limited worth?
The market values Jubilant Ingrevia Limited at about ₹93.9B (market capitalisation, as of Nov 15, 2026). Per share that is ₹591.50; our models calculate a fair value of ₹387.66 per share.
What do the bullish and bearish scenarios say about JUBLINGREA?
Our models span a range for Jubilant Ingrevia Limited: cautious scenario ₹202.70, base ₹387.66, optimistic ₹484.57 per share (as of Nov 15, 2026, price ₹591.50). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of JUBLINGREA?
Jubilant Ingrevia Limited trades at a price-to-earnings ratio of 29.2 (as of Nov 15, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹387.66 is built from several models across several years. Median P/E at fiscal year-end, 6 fiscal years (2021 to 2026), reported earnings: 35.1. Other multiples: P/B 3.0, P/S 1.9, EV/EBITDA 13.4.
How solid is the balance sheet of Jubilant Ingrevia Limited (JUBLINGREA)?
Balance-sheet figures for Jubilant Ingrevia Limited (as of Nov 15, 2026): return on equity 11.0%, debt of 0.10 per unit of equity. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is JUBLINGREA from its 52-week high?
Jubilant Ingrevia Limited trades at ₹591.50, about 22% below its 52-week high of ₹761.24 and 10% above the low of ₹539.48 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of ₹387.66 is for.
Which stocks are comparable to Jubilant Ingrevia Limited?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Jubilant Ingrevia Limited stock attractive at the current price?
The data as of Nov 15, 2026: price ₹591.50, calculated fair value ₹387.66 (−35%), Quality Score 55/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of JUBLINGREA calculated?
We run Jubilant Ingrevia Limited through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹387.66 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Jubilant Ingrevia Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Jubilant Ingrevia Limited (JUBLINGREA)?
The closing price on Nov 16, 2026 was ₹591.50. Our model-based fair value is ₹387.66, about 35% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Jubilant Ingrevia Limited right now?
The price sits above even our optimistic bull case (₹484.57). The favourable scenario is already priced in. Solid but not exceptional quality (55/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (₹202.70 to ₹484.57) leaves room in how you read the outcome.

Key figures of Jubilant Ingrevia Limited

How large is the market capitalisation of Jubilant Ingrevia Limited (JUBLINGREA)?
The market capitalisation of Jubilant Ingrevia Limited is ₹93.9B (≈ $1,000M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Jubilant Ingrevia Limited (JUBLINGREA)?
The price-to-sales ratio of Jubilant Ingrevia Limited is 1.91 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Jubilant Ingrevia Limited (JUBLINGREA)?
Earnings per share at Jubilant Ingrevia Limited are ₹20.29 (price ÷ EPS = P/E 29.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Jubilant Ingrevia Limited (JUBLINGREA)?
The dividend yield of Jubilant Ingrevia Limited is 0.8% (payout 24.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Jubilant Ingrevia Limited (JUBLINGREA)?
The net margin of Jubilant Ingrevia Limited is 7.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Jubilant Ingrevia Limited (JUBLINGREA)?
The return on equity (ROE) of Jubilant Ingrevia Limited is 11.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Jubilant Ingrevia Limited (JUBLINGREA)?
On an EBIT basis the return on assets of Jubilant Ingrevia Limited is 10.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Jubilant Ingrevia Limited (JUBLINGREA)?
The operating margin of Jubilant Ingrevia Limited is 12.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Jubilant Ingrevia Limited (JUBLINGREA)?
Revenue at Jubilant Ingrevia Limited is growing 25.2% versus a year earlier (3y avg −2.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Jubilant Ingrevia Limited (JUBLINGREA)?
Earnings per share at Jubilant Ingrevia Limited are growing 60.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Jubilant Ingrevia Limited (JUBLINGREA) carry?
The net debt of Jubilant Ingrevia Limited is ₹6.0B (fiscal year 2026, ≈ 3.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Jubilant Ingrevia Limited in the live analysis

One click puts Jubilant Ingrevia Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.